UB
HRMY icon

UMB Bank’s Harmony Biosciences HRMY Stock Holding History

UMB Bank’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.42K Buy
94
+21
+29% +$662 ﹤0.01% 2142
2026
Q1 		$2.04K Sell
73
-109
-60% -$3.57K ﹤0.01% 2163
2025
Q4 		$6.81K Buy
182
+18
+11% +$592 ﹤0.01% 1945
2025
Q3 		$4.52K Buy
164
+28
+21% +$965 ﹤0.01% 1903
2025
Q2 		$4.3K Buy
136
+64
+89% +$2.06K ﹤0.01% 1866
2025
Q1 		$2.39K Sell
72
-20
-22% -$717 ﹤0.01% 1938
2024
Q4 		$3.17K Buy
92
+26
+39% +$893 ﹤0.01% 1842
2024
Q3 		$2.64K Buy
66
+36
+120% +$1.26K ﹤0.01% 1912
2024
Q2 		$905 Buy
30
+18
+150% +$541 ﹤0.01% 1996
2024
Q1 		$403 Buy
+12
New +$385 ﹤0.01% 2031
2023
Q4 		– Sell
-219
Closed -$7.18K – 1669
2023
Q3 		$7.18K Sell
219
-310
-59% -$10.8K ﹤0.01% 1355
2023
Q2 		$18.6K Hold
529
– – ﹤0.01% 1112
2023
Q1 		$17.3K Buy
529
+329
+165% +$15K ﹤0.01% 1121
2022
Q4 		$11K Buy
+200
New +$11K ﹤0.01% 1276

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UMB Bank's HRMY Position: Q2 2026 in Review

UMB Bank increased its Harmony Biosciences (HRMY) stake by 29% in Q2 2026, buying an estimated $662 and bringing the position to 94 shares worth $3.42K. The position accounts for ﹤0.01% of the portfolio, ranked #2142.

UMB Bank first reported a position in HRMY in Q4 2022 and has held it in 14 quarters since. The position peaked at $18.6K in Q2 2023. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • UMB Bank held 94 shares of Harmony Biosciences worth $3.42K as of Q2 2026.
  • UMB Bank bought 21 Harmony Biosciences shares in Q2 2026, an estimated $662.
  • Harmony Biosciences made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #2142 holding.
  • UMB Bank first reported a position in Harmony Biosciences in Q4 2022 and has held it in 14 quarters since.
  • UMB Bank's Harmony Biosciences position peaked at $18.6K in Q2 2023.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.